Arkolith/Insider Trading/TRAW/Form 4/A

Dukes Iain D.

Executive Chairman, DirectorTraws Pharma, Inc. (TRAW) · full profile →Form 4/A · filed Aug 7, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2024Grant(A)68K——134K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0000929638-24-002743) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML